Meribank Biotech Co (ROCO:4724) Total Inventories : NT$6.9 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Total Inventories?

Meribank Biotech Co's total inventories for the quarter that ended in Dec. 2023 was NT$6.9 Mil. Meribank Biotech Co's average total inventories from the quarter that ended in Jun. 2023 to the quarter that ended in Dec. 2023 was NT$7.7 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Meribank Biotech Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was NT$1.46.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Meribank Biotech Co's Days Inventory for the six months ended in Dec. 2023 was 26.98.

Inventory Turnover measures how fast the company turns over its inventory within a year. Meribank Biotech Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 6.77.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Meribank Biotech Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.06.

Meribank Biotech Co Total Inventories Historical Data

The historical data trend for Meribank Biotech Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Total Inventories Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

2.65

2.94

3.60

8.45

6.91

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Inventories	Get a 7-Day Free Trial							3.60	6.31	8.45	8.46	6.91

Meribank Biotech Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Meribank Biotech Co (ROCO:4724) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Meribank Biotech Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(399.458	+	0.75 * 134.545	+	0.5 * 6.907	-	390.812
-	0	-	9.464)	/	70.9764
=	1.46

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Meribank Biotech Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	7.6855	/	51.995	*	365 / 2
	=	26.98

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Meribank Biotech Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	51.995	/	7.6855
	=	6.77

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Meribank Biotech Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	7.6855	/	131.28
	=	0.06

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Meribank Biotech Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines